chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Memory loss; This spontaneous case was reported by a consumer and describes the occurrence of AMNESIA (Memory loss) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AMNESIA (Memory loss). At the time of the report, AMNESIA (Memory loss) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
23APR91 exp fever of 103.6 w/severe h/a; Also shivering; tx Panadol
This spontaneous report as received from a pharmacist via a field employee refers to a male patient of about 70 years of age. The patient's current condition included heart disease. On an unknown date, the patient was vaccinated with ZOSTAVAX (dose, route and lot number not reported). On the same date, 40 minutes after the injection the patient experienced a minor transient ischaemic attack (TIA). On an unspecified date, the patient recovered from transient ischaemic attack. No further details was provided. Causality assessment was not provided. Additional information has been requested.
cough, injected burning conjuncting 4hrs p/vax then 6hrs later devel fever & chills
received a third dose; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 51-year-old male patient who received Herpes zoster (Shingrix) (batch number 5F3T5, expiry date 26th May 2023) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 16th August 2021) and Shingrix (received 2nd dose on 18th November 2021).   On 4th March 2022, the patient received the 3rd dose of Shingrix. On 4th March 2022, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional details were provided as follows: Nursing assistant at clinic reported that, the patient received first two doses of Shingrix and had no symptoms reported. On the day of reporting, the patient received third dose of Shingrix, which led to extra dose administered. The reporter requested additional information on possible side effects of third dose being administered, warm transferred. The reporter consented to follow up.
1/3/21 Sinus pressure, loss of smell, cough, SOA with exertion, HA, fatigue, sore throat, ear pain
Information has been received from a nurse practitioner concerning a 15 year old female with a history of fever of 102.5 degree a week prior to being vaccinated who on 01-MAR-2007 was vaccinated with Gardasil. In March 2007, soon after vaccination with Gardasil, the patient developed labia lesions. The patient was not sexually active. On 05-MAR-2007, the patient was seen for an office visit. The lesions were cultured and sensitivity of the lesions were negative for bacterial, fungal and viral infections. As of 05-MAR-2007, the patient's labia lesions persisted. Additional information has been requested.
No adverse effect; Patient received improperly stored VAQTA; Information has been received from a Certified Medical Assistant concerning to a 6 year old male patient. No medical history, concurrent conditions nor concomitant medications were reported. On 01-NOV-2019, the patient was vaccinated with an improper stored dose of hepatitis a vaccine, inactivated (VAQTA), 25/0.5 (units not reported) (lot No. S009562, expiration date reported as 26-JUL-2020, conflicting information as per internal verification was 05-MAY-2019) (route not reported) for prophylaxis. No adverse event was reported.   Temperature timeframe: Above 47°F (52.09 F) for 1.39 hours Previous temperature excursion: Above 47°F (64.83 F) for 13.35 hours Call made because of data logger: Yes
Fever of 100.7, chills, bad headache, joint pain, pain in lower back, upset stomach.
Patient received vaccine at 1444, c/o lightheadedness and dizziness. Patient was instructed to lie down, offered water and apple juice, and observed for 30 mins. Patient discharged home at 1535.
Light flu, cough with high fever which goes away with Tylenol but comes back if stopped.
Myalgia, CoughWheeze,  pain at injection site  Narrative:  Per supervisor report: "[3/12] right arm pain, neck pain, cough, low grade temp."  Other Relevant History:
Developed Immune Peripheral Neuropathy in both hands and feet with numbness and tingling that has not gone away. Easily fatigued and more sensitive to warm temperatures. Development of cysts on liver and kidneys with dull aching pain in Rt. upper side of abdomen since Dec. 2012.
Fever T max 102.8 degrees F. Treated with paracetamol 100 mg/ml. Fever has started 54 hours after the injections.
Pt w/congenital heart disease (pulmonary artresia & VSD) w/chronic desaturation but otherwise stable; pt was irritable p/vax & that noc became more irritable & difficult to console; became limp & cyanotic; EMTs called-taken to ER;
This was an unauthorized 4th dose of the COVID-19 vaccine. No actual adverse events observed.
Post vax, the pt developed a 2 inch x 2 inch hematoma, hard, hot to the touch with edema.
Pt. complains of pain and swelling in hands and feet. Both vaccination sites still warm to touch. I noted on 9/15/09 mother of child, she had yes recovered. 9/9/09 Spoke with pt who did not see any treating MD, took ibuprofen and Benadryl as advised by HD, pt still has slight itching but is improving. No f/u required.  Case closed.
Patient was less than recommended age for vaccination. There were no adverse events reported from patietn or parents. Incorrect vaccination was selected for age.
Expired dose administered to patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patients) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patients). On 06-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment medication was provided. Some patients had reported flu-like symptoms after receiving the vaccination.
It started with weakness, fatigue, and joint pain. By the afternoon on the day following the shot I had severe chills and my feet hurt as if cramping but there were no cramps. I also had a fever of 103° F and a severe headache.
I woke up with an intense migraine the morning after my second vaccine dose. The migraine lasted the entire day (day 2). I also had a fever, muscle and joint aches, fatigue, and swollen lymph nodes in my neck and armpit that second day. The third and fourth day the migraine turned into a headache for both days. I then got a 2 day break of no migraine or headache (day 5 and 6). Then day 7, I got another headache that turned into a migraine on day 8. This was followed by an additional 3 days of a headache.
Thurs, Nov 4 2:45pm first vaccine dose. Only minor arm discomfort for Thursday and Friday. Some fatigue on Saturday and Sunday. By Monday afternoon, November 8 she started having unexplained high blood sugar reading (via cgm). This continues for three full days so far and caused her to miss one day of online school. It is if there is massive insulin resistance -- that we giver her insulin to cover meals but the insulin does not act how it normally does (we switched pods and insulin bottles to ensure it was not an equipment issue). She is 10 and has some puberty hormonal bg swings but we have not seen anything like this. The insulin, though supposed to start to take effect in 15 minutes is taking many hours. By then we have over corrected and then she crashes low. In comparison to previous weeks, she is far above her average time in range, average bg number and standard deviation with 176bg, 51% in range , 10% very high and 60 SD.  The week before in comparison was 150bg, 65% in rance, 1% very high and 42SD. These numbers do not show the immense fear and exhaustion that this has caused. We just want people to be aware that for Type 1 kids there may be a delayed amount of bg highs and lows due to increased insulin resistance. As T1D parents we always expect bg swings with any medicine or vaccine but this has been very different and social media searches indicate this is happening to others though overlooked and underreported as this is considered a 'normal' response. But the severity needs to be noted. My kiddo should never be 400+ after eating anything if she has insulin on board. It is very scary and just want someone to know. We hope this wears off soon. Thank you.
pt reports onset of strange feeling on lt site of face 4PM 19NOV96;recv flu vax 2PM same day;woke up following morning unable to smile on that side, lt eye twitching;had inc tearing from lt eye & no taste w/tongue;c/o mouth droop;upset;
Edema, redness, warmth and itching to right upper arm.  BENADRYL cream and ice to site.
pt received 1st dose of moderna vaccine  on 4/18/21 at store. She reports no sxs until the morning of 4/26/21. Pt woke up with red, itchy spot at injection site, reports this is her only symptom. She said she will take cetirizine to help with itching. We contacted her the next day on 4/27/2021 and she reports the spot is getting smaller and less itchy, we will continue to check in with her until this resolves.
Client received .5 ml of adult dose of HEP A vaccine  No adverse reactions noted  Attempted to notify parents of med error - unable to contact
Information has been received from a physician concerning an "about" 65 year old patient who in September 2007, was inadvertently vaccinated SC with a 0.5mL dose of varicella virus vaccine live (Oka/Merck) instead of zoster vaccine live (Oka/Merck) (MSD). Medical attention was sought in the office. It was reported that this was not product confusion. There was no product quality complaint involved. Additional information has been requested.
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 48-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 02-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Rx number was reported.  No treatment medication was reported.
injection site soreness; fatigue; bedridden; labelled drug drug interaction; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2019-2020 season) for prophylaxis.   In October 2019, the patient received the 1st dose of Shingrix and the 1st dose of Influenza vaccine Quadrivalent 2019-2020 season. On an unknown date, less than 3 months after receiving Shingrix and Influenza vaccine Quadrivalent 2019-2020 season, the patient experienced injection site pain, fatigue, bedridden and labeled drug-drug interaction medication error. On an unknown date, the outcome of the injection site pain, bedridden and labeled drug-drug interaction medication error were unknown and the outcome of the fatigue was recovered/resolved.   It was unknown if the reporter considered the injection site pain, fatigue and bedridden to be related to Shingrix and Influenza vaccine Quadrivalent 2019-2020 season.  Additional information received were as follows: The age at vaccination was not reported but it could be 76 or 77 years old. The patient received the first dose of the Shingrix vaccine with a Influenza vaccine Quadrivalent 2019-2020 season in left arm, which led to labeled drug-drug interaction medication error. The patient experienced some injection site soreness and she states she felt extremely fatigue that she could not get out of bed. The fatigue resolved before the 24 hour mark. No additional information provided. Consent to follow up was denied.
sore arm, headache, whole arm intense itching, hives and swelling (had to remove all rings)
I had an intense warm feeling in my arm a few minutes after the injection, which seemed to spread down to my hand. After a while, the feeling transferred to my left leg, It's best described as a moving hot flash, which starts in my thigh and ends in my foot over the course of a second or two. I though it would go away. Co-workers reported also feeling that warm sensation travelling through their arm and chest  for the night after receiving the vaccine (we all got it at about the same time), but to my knowledge I am the only one who is still feeling it, weeks later. It was more intense and constant in the week following the vaccine. Now I will feel it once or twice a day. I am  hoping it will go away, but mostly I just want to document it so that other people who feel it know that they are not alone. I saw a paper in the literature which was a case study of one woman experiencing something similar, but she termed it "burning,"  whereas I find it not to be burning, but an intense warmness, like a traveling hot flash. I guess in the end it is some sort of paresthesia.
This spontaneous report as received from a health professional refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 23-NOV-2015, the patient was vaccinated with improperly stored (exposed to the following temperatures and cumulative time frames colder than 36 F: In September 2015, the coldest temperature was 34 F for 346.7 hours (over 14 days); In October of 2015, the coldest temperature was 34 F for 492.6 hours for a total of 839.3 hours (35 days); In November of 2015, the coldest temperature was 34 F for 192 hours, for a total of 1,031.3 hours (43 days)) VAQTA injection, 0.5 ml (lot # L023936, exp. date: 15-MAR-2017) (route and strength unspecified). No concomitant medications were reported. No adverse effects have been reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
From initial information received on 4/15/04 from a workman's compensation representative regarding an adverse event occurring in the USA, it was reported that a 50 year old male patient received a dose of IMOVAX RABIES in the left arm on 3/31/04. The lot number, route and dose number were not reported. It was not reported whether the patient received the product as part of a pre- or post-exposure series. On 4/7/04, the patient complained of headache and sleeplessness. It was reported that he felt nervous and edgy and became argumentative. He also had a very sore left arm at the site of injection. He was seen by a physician and had not yet recovered from these events at the time of this report.
12 hours after my vaccination (first dose of Moderna covid vaccine)  and while sleeping,  I suddenly started having numerous muscle aches and a slight headache and fatigue that persisted for another 24 hours or so. I also has some intestinal trouble with pain and a bout of diarheea, which I haven't had in years. 48 hours later I feel back to normal with no pain or fatigue of any kind.
Symptoms: Pain, swelling, hives, numbness, tingling, coldness to left arm from site up into shoulder and down to thumb. Thumb turned deep purple. Began 36-48 hours after shot and continued for additional 24 hours. Treatment: ice and Ibuprofen.
Pt received first dose / on oct 2019 (2 years ago ) never got the 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of no adverse event (received 1st dose of Shingrix in October 2019 (2 years ago), batch number-3553N.).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details was reported as follows: The age at vaccination was not applicable for this report. Till the time of reporting, patient did not received the 2nd dose of shingrix, which led to incomplete course of vaccination. The reporter stated that, no other details of vaccine were available. The reporter consented to follow up.
Tachycardia and throat and chest tightening with second dose of Pfizer-BioNTech COVID-19 vaccine 0.3 mL IM in left deltoid.  Called RRT. Patient took diphenhydramine 25 mg PO, and taken to ED for monitoring. ECG normal. Given 1 L NS and vitals monitored for 2 hours. Symptoms resolved and patient discharged in stable condition.
Pt seen for well child check by provider at 8 AM 12/12/12. Mother reported 12/13/12 that he had a temp of 103 8PM (approx 12 hrs later). Resolved with fever reducer obtained over the counter.
Slight vaginal bleeding, I haven't had my period in almost 15 years. Pain running through my left hip. Constant headache.
The patient claims she has Rash and blood pressure has been fluctuating . She said she took 1 capsule 50mg of Benadryl for the rash and it has since disappeared. But the blood pressure is still yet to be controlled.
Injection site got very red, itchy and slightly swollen. It is still that way, in fact redder today than yesterday. Today is Saturday, received vaccine on Tuesday. Started on Thursday evening.
SUBSEQUENT "PAIN IN NECK AND ITCHING ON LEFT SIDE" WERE RELATED TO VACCINE AND WAS REFERRED TO PHYSICIAN FOR EVALUATION.  PATIENT REPORTED A VISIT TO PROVIDER AND SAID THE PAIN AND ITCHING WERE GETTING BETTER. PROVIDER TOLD PATIENT TO LET THEM KNOW IF SYMPTOMS WORSEN OR DON'T GET BETTER.
Induration, erythema cellulitis reaction 24 hr post administration 8in x 5in area deltoid area
Following the first vaccine on 2/3/21 I just had localized arm soreness. Following the second vaccine on 3/10/21 I experienced mild flu-like symptoms with chills, achiness, brain fog and fatigue. All of the symptoms have resolved except for fatigue.  Fatigue is on-going.  I just feel different and have to take a nap during the day (when possible) due to lack of energy.
(L) deltoid swollen 5cm x 8 cm red, hot to touch, tender after 24 hrs.
I was sitting down and got up. I started walking and kept going to the left. I started sweating. I had dry heaves. I call an ambulance. My wife said I was white as a ghost. They took me to the ER where I was admitted there. They did the blood work, CT scan, MRI of my lungs and brain. They diagnosed was Transient Ischemia attack. I had a TIA, which is a mini stroke.
(1) Pulmonary embolism:        Unclear whether there had been a provoking event.  Reports symptoms for about a week.  Left lower extremity VTE found on ultrasound requested by her PCP.  She reports she may have had COVID-19 in December.  She reports she had just completed second dose of COVID-19 vaccine on 4/15.  Appears it would give about 7 days since the second dose, and onset of her symptoms. She does state she had been somewhat less mobile after her illness.  She does not smoke.  She is not on any hormone therapy. Not entirely clear that this is related to the vaccination, however, will discuss with pharmacy regarding whether this should be reported. We discussed anticoagulation.  She started on Lovenox and ER.  Discussed subsequently switching to oral anticoagulation. We will assess TTE.  Monitor oxygenation, blood pressure, heart rates.       Status: Acute (2) Deep vein thrombosis of lower extremity:        Initiated on anticoagulation as above.  Ultrasound reports VTE including common femoral vein.  We will try to see if we can get a limited study to assess more proximal veins.  Discussed with her in case of concern symptoms, iliofemoral VTE, consideration may be given as well to catheter directed TPA.  She understands that this procedure is not available at the current facility. We discussed also regarding possibility of post phlebitis syndrome, especially with more proximal VTE.  Discussed strategies going forward to reduce the symptoms.
Information has been received from a health professional concerning an 8 wk old female, with no medical history and no allergies who on 10Jul06 was vaccinated with one oral viral of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human bovine) (lot 653981/0411F). Concomitant vaccines included a dose of pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (CRM197) (Prevnar), a dose of diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid, a dose of poliovirus vaccine inactivated and a dose of Hib conj vaccine (manf unk). It was reported that on 10Jul06, while administering rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human bovine) the pt swallowed twice and then began to vomit. It was reported that the pt recovered on 10Jul06. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
This spontaneous report was received from a physician refers to a patient of unknown demography. On 14-APR-2014, the patient was vaccinated with VARIVAX Lot # J009729 (Expiry: 29-OCT-2014) (dose, route and frequency were not reported) and M-M-R II Lot # J003787 (Expiry: 07-JUN-2015) which were exposed to 13C for 68 hours. No adverse effects were reported. No further information was provided. This case is linked to the case 1404USA008994 and 1404USA010753 (same reporter link). Additional information has been requested.
Confusion, Dizziness, Hallucinations, Headache, Myalgia, Fever & Diarrhea  Narrative:
Pt states she received CoVid bivalent Pfizer and influenza vaccine in a.m and developed facial swelling and bruising on the side of CoVid vaccine in the p.m.